Bookmark

Add to MyYahoo RSS

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

3 hrs ago | PhysOrg Weblog

Johnson & Johnson pulls hysterectomy tool tied to cancer risk from market

The largest maker of a surgical tool that has shown an increased risk of spreading undetected cancers in women has said it will withdraw its device from the market.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

7 hrs ago | Wall Street Journal

Johnson & Johnson Partners with CircleUp for Early Look at Startups

CircleUp COO Rory Eakin and CEO Ryan Caldbeck with an array of products made by companies that raised equity funding on their site.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

12 hrs ago | TheStreet.com

Why Johnson & Johnson (JNJ) Stock Is Lower Today

The company plans to tell customers world-wide in a letter today to return the devices known as laparoscopic power morcellators, the Journal said, STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

16 hrs ago | Medical News

Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

17 hrs ago | National Public Radio

Senate Antitrust Panel Eyes Contact Lens Pricing Policies

Under "UPP," or universal pricing policies, manufacturers like Johnson & Johnson tell retailers they can't sell their contact lens below a certain price.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

20 hrs ago | Reuters

Press Digest - Wall Street Journal - July 31

The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

Comment?

Related Topix: Reuters, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Wed Jul 30, 2014

Business Journal

Johnson & Johnson recalls power morcellators

A surgical device maker on Wednesday issued a voluntary worldwide recall of its products because of the risk of spreading undetected cancer.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Ledger-Enquirer.com

J&J withdraws fibroid treatment device from market

In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Business Journal

Dendreon appoints retired Johnson & Johnson exec as new CEO

Seattle cancer drug-maker Dendreon has named 71-year-old retired biotech executive W. Thomas Amick as the company's new CEO.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Dendreon, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

The Montreal Gazette

Hot ointment works its way back through vendors on judge's orders

In a complicated ruling this month, Superior Court Judge Donald Bisson quashed two separate sales of 47,088 tubes of Polysporin ointment - one of them to the Jean Coutu pharmacy chain - on the grounds the goods transacted never really belonged to the parties selling them.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

BioResearch Online

J&J And Organovo Link For 3D-Printing Drug Discovery

Johnson & Johnson company Janssen Research and Development announced that it is has entered into collaboration with bioprinting firm Organovo to investigate 3D printing of living tissue for drug discovery and research.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Adrants

Without Admitting Their Products Where Ever Bad, Johnson's Touts Reformulated Baby Products

Without admitting the ingredients formaldehyde and 1,4-dioxane, present in 100 of its baby products, Johnson's Baby, which earlier this year began introducing reformulated products, is out with a delightfully fuzzy, feel good campaign touting the removal of those ingredients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Life, Hobbies, Origami

Freshnews

Milestone Scientific Appoints Senior Healthcare Industry Executive...

Milestone Scientific Inc. , a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.

Comment?

Related Topix: Marketing, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Reuters

UPDATE 1-U.S. Senate panel to look into price setting for contact lenses

Moves by three of the four major U.S. contact lens makers to set price floors for many of their products, preventing low-cost retailers from discounting the expensive devices, have drawn scrutiny from lawmakers.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Bausch and Lomb, Medical Equipment, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics

Tue Jul 29, 2014

Beet.TV

JWT's Branded Content Approach Starts with Participation

Branded content is not an "if" for marketers; it's a must-have, says Eric Weisberg, Executive Creative Director at JWT , in an interview with Beet.TV.

Comment?

Related Topix: Native Advertising, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Family, Kids

ZDNet

IBM board adds Johnson & Johnson CEO, former Royal Dutch Shell CEO

Closing out a month that included a landmark deal with Apple, IBM is boosting its board of directors with two new additions who are seasoned chief executives.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Seeking Alpha

3 Core Dividend Growth Stocks For Retirement Income

There are multiple ways to fund or supplement your expenses in retirement - selling part of your retirement portfolio each year, getting a reverse mortgage if you own your home, buying high-yielding dividend stocks, owning bonds, etc.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Home, Mortgage, Home Buying, Biotech, Medicine, Healthcare Industry

Seeking Alpha

Catalent IPO Should Rock Given Blackstone Backing

CTLT is a leader in a field with massive barriers to entry; and has done particularly well under Blackstone's leadership .

Comment?

Related Topix: Somerset, NJ, Blackstone Group, Advertising, Biotech, Medicine, Healthcare Industry, Pfizer, Teva Pharmaceutical Industries

Seeking Alpha

Should I Invest In AT&T And Verizon For Their High Dividend Yields?

However, the expected growth in earnings and distributions is most likely to match the expected rate of inflation in the foreseeable future.

Comment?

Related Topix: AT&T, Startups, Cable & Satellite, Telecom, Versant, ATT, Verizon Communications, Verizon, IT Services, Biotech, Medicine, Healthcare Industry

Mon Jul 28, 2014

The Hill

Business Bottom Line

TECHNOLOGY. Last year, the Pentagon struck a deal with wireless carriers to give them a coveted band of spectrum for commercial use.

Comment?

Related Topix: T-Mobile, Department of Defense, US News, US Politics, US Senate, John McCain, Republican, Immigration Reform, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••